Source: BioSpace

SWK: PDL BioPharma Announces Sale of Kybella, Zalviso and Coflex Royalties to SWK Holdings Corporation

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty interests for Kybella ® , Zalviso ® , and Coflex ® (collectively the "Royalties") to SWK Funding, LLC ("SWK"), a wholly owned subsidiary of SWK Holdings Corporation (Nasdaq: SW

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
CEO Avatar

CEO

Winston Black

CEO Approval Rating

79/100

SWK is a finance company that provides capital to a range of life science companies, institutions and inventors. Read more